Pure Global
NCT05269992

Childrens Real Food Tolerance Study

Tolerance, Compliance and Acceptability to a New Nutritional Feed Comprising Real Food Ingredients
Nutricia UK Ltd·ClinicalTrials.gov·otherNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Malnutrition, Child
Drug/Device/Intervention
Real food products
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Nutricia UK Ltd
Timeline & enrollment
Phase
N/A
Start date
Apr 01, 2022
End date
Dec 01, 2023
Enrollment
60 participants
Primary outcome

Gastrointestinal tolerance assessing abdominal discomfort, pain, nausea, reflux, regurgitation, gagging, retching, vomiting, constipation, diarrhoea, bloating and flatulence

Summary

A prospective, longitudinal, 28-day intervention study evaluating the tolerance, compliance,
 acceptability and safety to two new enteral tube feed and one new oral nutritional supplement
 based on real food ingredients (1kcal/ml and 1.5kcal/ml enteral tube feeds and a 1.5kcal/ml
 oral nutritional supplement).

ICD-10 classifications
MalnutritionMalnutrition in pregnancySequelae of malnutrition and other nutritional deficienciesMalnutrition-related diabetes mellitusMalnutrition-related diabetes mellitus with unspecified complications
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05269992
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05269992 through Pure Global AI's free database. This phase not specified trial is sponsored by Nutricia UK Ltd and is currently Not yet recruiting. The study focuses on Malnutrition, Child. Target enrollment is 60 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.